Solr Search

rogressive degeneration of the brain’s frontal and temporal lobes., About the Kissick Family Foundation FTD Grant Program  The Kissick Family Foundation partnered with MI Philanthropy’s Science and Health team in 2022 to analyze and understand the state of the FTD research ecosystem and identify where phi, , Please

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

ve placed new pressures on the corporate sector.

easing its first Request for Proposals (RFP) to fund research that accelerates basic and fundamental discoveries for sporadic FTD.

in behavior, mood, executive function, language, memory, and motor function.